Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FUSN just taken over.

<< Previous

Bullboard Posts

Next >>

Comment by rhodiumdon Mar 19, 2024 12:40pm

156 Views

Post# 35940859

RE:RE:RE:FUSN just taken over.

$2.4B since there ia a potential for a considerable reward.

Prostate cancer is the second most common type of cancer in the US, compared to bladder cancer which comes in 6th place:

Breast (Female – Male)	297,790
Prostate	288,300
Lung (Including Bronchus)	238,340
Colon and Rectal (Combined)	153,020
Melanoma	97,610
Bladder	82,290
Kidney (Renal Cell and Renal Pelvis)	81,800
Non-Hodgkin Lymphoma	80,550
Endometrial	66,200
Pancreatic	64,050
Leukemia (All Types)	59,610
Thyroid	43,720
Liver and Intrahepatic Bile Duct	41,210